Acción UCBJY UCB SA
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Empresa UCB SA OTC Markets

Acciones

UCBJY

US9034801012

Farmacéuticos

Diferido OTC Markets
Otros sitios de cotización
 20:30:01 10/06/2024 		Varia. Cinco días. Varia. 1 de enero.
69,98 USD -0,38 % Gráfico intradía de UCB SA +0,66 % +60,50 %
20/05 OPINIONES DE LOS ANALISTAS DEL DÍA : Aedas, Endesa, Tubacex, Sabadell, BBVA, Unicaja, Repsol, Iberdrola, Nvidia, Intel, Richemont, Micron Technology... Our Logo
23/04 OPINIONES DE LOS ANALISTAS DEL DÍA : Galp Energia, STMicroelectronics, UBS, Acs, Telefónica, Endesa, UBS, Ence Energía, Bankinter... Our Logo

Resumen de negocios

UCB es una empresa biofarmacéutica mundial centrada en el descubrimiento y desarrollo de medicamentos y soluciones innovadoras para transformar la vida de las personas que padecen enfermedades graves del sistema inmunitario o del sistema nervioso central.

Número de empleados: 8 767

Ventas por actividad

EUR en millones2022Peso2023Peso Delta
Biopharmaceuticals
100,0 %
5 140 100,0 % 4 867 100,0 % -5,31 %

Ventas por región

EUR en millones2022Peso2023Peso Delta
United States
50,4 %
2 902 56,5 % 2 454 50,4 % -15,44 %
Other Countries
11,4 %
507 9,9 % 554 11,4 % +9,27 %
Europe - Other
7,5 %
348 6,8 % 365 7,5 % +4,89 %
Germany
6,4 %
330 6,4 % 310 6,4 % -6,06 %
Japan
5,5 %
324 6,3 % 269 5,5 % -16,98 %
Spain
4,6 %
213 4,1 % 224 4,6 % +5,16 %
France (including French Territories)
3,3 %
169 3,3 % 162 3,3 % -4,14 %
China
3,1 %
159 3,1 % 151 3,1 % -5,03 %
Italy
2,9 %
154 3,0 % 143 2,9 % -7,14 %
United Kingdom and Ireland
2,7 %
151 2,9 % 133 2,7 % -11,92 %
Belgium
1,1 %
49 1,0 % 52 1,1 % +6,12 %
Global
1,0 %
-167 -3,2 % 50 1,0 % -129,94 %

Directores

Directores PuestoEdadDesde
Jean-Christophe Tellier CEO
 Chief Executive Officer 65 01/06/11
Sandrine Dufour DFI
 Director of Finance/CFO 57 01/07/20
Dhavalkumar Patel CTO
 Chief Tech/Sci/R&D Officer 63 01/10/17
Kirsten Lund Jurgensen CTO
 Chief Tech/Sci/R&D Officer 65 01/01/19
Iris Löw-Friedrich CTO
 Chief Tech/Sci/R&D Officer 63 01/09/06
Antje Witte IRC
 Investor Relations Contact - -
Dominique Baeten PRN
 Corporate Officer/Principal - -
Thomas Debeys AUD
 Comptroller/Controller/Auditor - -
Jean Fleurial HRO
 Human Resources Officer 59 01/09/17
Emmanuel Caeymaex PRN
 Corporate Officer/Principal - 01/03/94

Administradores

Administradores PuestoEdadDesde
Ulf Arne Wiinberg BRD
 Director/Board Member 66 28/04/16
Dame Davies BRD
 Director/Board Member 73 01/01/14
Jean-Christophe Tellier CEO
 Chief Executive Officer 65 01/06/11
Cyril Janssen BRD
 Director/Board Member 53 01/01/15
Jonathan Peacock CHM
 Chairman 66 01/01/21
Maëlys Castella BRD
 Director/Board Member 58 01/01/23
Jonkheer Cédric van Rijckevorsel BRD
 Director/Board Member 54 24/04/14
Charles-Antoine Janssen BRD
 Director/Board Member 53 01/01/01
Susan Gasser BRD
 Director/Board Member 69 01/01/21
Pierre Gurdjian BRD
 Director/Board Member 63 28/04/16

Clase de acciones

VoteQuantityFlotanteAutocontrolTotal Float
Acción A 1 194 505 658 119 501 352 ( 61,44 %) 4 755 075 ( 2,445 %) 61,44 %

Accionistas

NombreAcciones%Valoración
FINANCIÈRE DE TUBIZE S.A.
36,04 %
70 090 611 36,04 % 9 334 M $
Wellington Management Co. LLP
6,555 %
12 749 947 6,555 % 1 698 M $
UCB
2,445 %
4 755 075 2,445 % 633 M $
FMR Investment Management (UK) Ltd.
0,4947 %
962 306 0,4947 % 128 M $
Wellington Management International Ltd.
0,3981 %
774 419 0,3981 % 103 M $
Mackenzie Investments Europe Ltd.
0,2381 %
463 204 0,2381 % 62 M $
Ibercaja Gestión SGIIC SA
0,2159 %
420 015 0,2159 % 56 M $
State Street Global Advisors Ltd.
0,1971 %
383 325 0,1971 % 51 M $
Argenta Spaarbank NV
0,1493 %
290 401 0,1493 % 39 M $
Apo Asset Management GmbH
0,1491 %
289 979 0,1491 % 39 M $
NombreAcciones%Valoración
RhumbLine Advisers LP
0,000990 %
3 852 0,000990 % 258 123 $
GAMMA Investing LLC
0,000032 %
125 0,000032 % 8 376 $
PNC Investments LLC
0,000001 %
5 0,000001 % 335 $

Participaciones

NombreAcciones%Valoración
UCB
2.44%
 4 755 075 2.44% 664 105 329 $

Información de la empresa

UCB SA

Allée de la Recherche, 60

1070, Brussels

+32 2 559 99 99

http://www.ucb.com
Dirección UCB SA(UCBJY)

Empresas del grupo

NombreCategoría y sector
UCB Manufacturing Ireland Ltd.
UCB Fipar SA
Logo UCB Fipar SA

UCB Fipar SA

Financial ConglomeratesFinance

Part of UCB SA, UCB Fipar SA is an investment holding Belgian company. The company is based in Anderlecht, Belgium. UCB Fipar was founded in 1947.

Financial Conglomerates
UCB Ventures Belgium SA
Investment Managers
UCB Pharma GmbH
Logo UCB Pharma GmbH

UCB Pharma GmbH

Pharmaceuticals: MajorHealth Technology

UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany.

Pharmaceuticals: Major
UCB Pharma SA (Belgium)
Logo UCB Pharma SA (Belgium)

UCB Pharma SA (Belgium)

Pharmaceuticals: MajorHealth Technology

UCB Pharma SA discovers and develops biopharmaceutical products. It is a biopharmaceutical company focuses on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. The company is headquartered in Brussels, Belgium.

Pharmaceuticals: Major
UCB Ventures SA
Investment Managers
Ucb Belgium SA
Logo Ucb Belgium SA

Ucb Belgium SA

Pharmaceuticals: MajorHealth Technology

Part of UCB SA, UCB Belgium SA is a Belgian bio-pharmaceutical company that focuses on neurology and immunology. The company is based in Brussels, Belgium. The company was founded by Emmanuel Janssen.

Pharmaceuticals: Major
UCB Pharma Ltd.
Logo UCB Pharma Ltd.

UCB Pharma Ltd.

Pharmaceuticals: MajorHealth Technology

UCB Pharma Ltd. operates as a biopharmaceutical company. The firm focuses on developing medicines for severe diseases in Immunology and CNS. The company is headquartered in Slough, the United Kingdom.

Pharmaceuticals: Major
UCB Biopharma SRL
Logo UCB Biopharma SRL

UCB Biopharma SRL

Medical DistributorsDistribution Services

Part of UCB SA, UCB Biopharma SRL is a Belgian pharmaceutical company founded in 2013. The company is based in Brussels, Belgium. UCB Biopharma specializes in the development of treatments for various medical conditions, including axial spondyloarthritis, psoriatic arthritis, and other health issues. The company also manages the UCB Community Health Fund and holds an annual shareholders meeting.

Medical Distributors

Sector

Salud
Farmacéutica e investigación médica
Farmacéuticos
Farmacéuticos
Biofármacos

Ventas por región

Notaciones para UCB SA

Calificación trading
Calificación Inversor
ESG Refinitiv
Más Ratings

Consenso de los analistas

Venta
Consenso
Compra
Recomendación promedio
ACUMULAR
Numero de análisis
19
Último precio de cierre
130 EUR
Precio objetivo promedio
126,4 EUR
Diferencia / Objetivo Promedio
-2,78 %
Consenso

Revisiones del BPA

Revisiones de las previsiones

Beneficios trimestrales - Tasa de sorpresa

La agenda de la empresa

Sector Biofármacos

Varia. 1 de ene. Capi.
CSL LIMITED Acción CSL Limited
+0,82 % 91,94 mil M
SAMSUNG BIOLOGICS CO.,LTD. Acción Samsung Biologics Co.,Ltd.
-3,16 % 38,74 mil M
BIOMARIN PHARMACEUTICAL INC. Acción BioMarin Pharmaceutical Inc.
-13,18 % 15,32 mil M
INCYTE CORPORATION Acción Incyte Corporation
-5,73 % 13,3 mil M
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Acción Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-11,38 % 11,65 mil M
ALTEOGEN INC. Acción ALTEOGEN Inc.
+156,85 % 10,37 mil M
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Acción Chongqing Zhifei Biological Products Co., Ltd.
-49,84 % 10,12 mil M
SWEDISH ORPHAN BIOVITRUM AB Acción Swedish Orphan Biovitrum AB
+2,32 % 9061,06 M
INNOVENT BIOLOGICS, INC. Acción Innovent Biologics, Inc.
-16,26 % 7456,69 M
Biofármacos
  1. Bolsa de valores
  2. Acciones
  3. Acción UCB
  4. Acción UCBJY
  5. Empresa UCB SA